{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:02:32Z","timestamp":1789549352895,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10067-026-08360-z","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T07:48:07Z","timestamp":1787384887000},"page":"5999-6009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic impact of autoimmune features in interstitial lung disease: a single-center retrospective real-world cohort study"],"prefix":"10.1007","volume":"45","author":[{"given":"Koki","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1666-0332","authenticated-orcid":false,"given":"Shuhei","family":"Shimoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yabusaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Horita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"8360_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h6819","volume":"352","author":"SC Mathai","year":"2016","unstructured":"Mathai SC, Danoff SK (2016) Management of interstitial lung disease associated with connective tissue disease. BMJ 352:h6819. https:\/\/doi.org\/10.1136\/bmj.h6819","journal-title":"BMJ"},{"key":"8360_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/2213-0802-2-4","volume":"2","author":"KC Meyer","year":"2014","unstructured":"Meyer KC (2014) Diagnosis and management of interstitial lung disease. Transl Respir Med 2:4. https:\/\/doi.org\/10.1186\/2213-0802-2-4","journal-title":"Transl Respir Med"},{"key":"8360_CR3","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1378\/chest.12-0741","volume":"143","author":"R Vij","year":"2013","unstructured":"Vij R, Strek ME (2013) Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest 143:814\u2013824. https:\/\/doi.org\/10.1378\/chest.12-0741","journal-title":"Chest"},{"key":"8360_CR4","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/13993003.00150-2015","volume":"46","author":"A Fischer","year":"2015","unstructured":"Fischer A, Antoniou KM, Brown KK et al (2015) An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 46:976\u2013987. https:\/\/doi.org\/10.1183\/13993003.00150-2015","journal-title":"Eur Respir J"},{"key":"8360_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.rmed.2019.03.011","volume":"150","author":"G Sambataro","year":"2019","unstructured":"Sambataro G, Sambataro D, Torrisi SE et al (2019) Clinical, serological and radiological features of a prospective cohort of interstitial pneumonia with autoimmune features (IPAF) patients. Respir Med 150:154\u2013160. https:\/\/doi.org\/10.1016\/j.rmed.2019.03.011","journal-title":"Respir Med"},{"key":"8360_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59040794","volume":"59","author":"F Bozzao","year":"2023","unstructured":"Bozzao F, Tomietto P, Baratella E et al (2023) Clinical characterization and predictive factors for progression in a cohort of patients with interstitial lung disease and features of autoimmunity: the need for a revision of IPAF classification criteria. Medicina (Kaunas) 59:794. https:\/\/doi.org\/10.3390\/medicina59040794","journal-title":"Medicina (Kaunas)"},{"key":"8360_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10173806","volume":"10","author":"H Yamakawa","year":"2021","unstructured":"Yamakawa H, Ogura T, Kameda H et al (2021) Decision-making strategy for the treatment of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). J Clin Med 10:3806. https:\/\/doi.org\/10.3390\/jcm10173806","journal-title":"J Clin Med"},{"key":"8360_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.resinv.2016.05.004","volume":"54","author":"M Okamoto","year":"2016","unstructured":"Okamoto M, Fujimoto K, Sadohara J et al (2016) A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung disease. Respir Investig 54:445\u2013453. https:\/\/doi.org\/10.1016\/j.resinv.2016.05.004","journal-title":"Respir Investig"},{"key":"8360_CR9","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1183\/13993003.01565-2015","volume":"47","author":"JM Oldham","year":"2016","unstructured":"Oldham JM, Adegunsoye A, Valenzi E et al (2016) Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J 47:1767\u20131775. https:\/\/doi.org\/10.1183\/13993003.01565-2015","journal-title":"Eur Respir J"},{"key":"8360_CR10","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.55563\/clinexprheumatol\/lycdca","volume":"41","author":"G Sambataro","year":"2023","unstructured":"Sambataro G, Sambataro D, Spicuzza L et al (2023) Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study. Clin Exp Rheumatol 41:1140\u20131148. https:\/\/doi.org\/10.55563\/clinexprheumatol\/lycdca","journal-title":"Clin Exp Rheumatol"},{"key":"8360_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1378\/chest.15-1145","volume":"149","author":"Y Hu","year":"2016","unstructured":"Hu Y, Wang L-S, Wei Y-R et al (2016) Clinical characteristics of connective tissue disease-associated interstitial lung disease in 1,044 Chinese patients. Chest 149:201\u2013208. https:\/\/doi.org\/10.1378\/chest.15-1145","journal-title":"Chest"},{"key":"8360_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/thoraxjnl-2020-216263","volume":"77","author":"N Enomoto","year":"2022","unstructured":"Enomoto N, Homma S, Inase N et al (2022) Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias. Thorax 77:143\u2013153. https:\/\/doi.org\/10.1136\/thoraxjnl-2020-216263","journal-title":"Thorax"},{"key":"8360_CR13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/resp.13665","volume":"25","author":"HC Kim","year":"2020","unstructured":"Kim HC, Lee JH, Chae EJ, Song JS, Song JW (2020) Long-term clinical course and outcome of interstitial pneumonia with autoimmune features. Respirology 25:636\u2013643. https:\/\/doi.org\/10.1111\/resp.13665","journal-title":"Respirology"},{"key":"8360_CR14","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1159\/000515396","volume":"100","author":"AS Jee","year":"2021","unstructured":"Jee AS, Parker MJS, Bleasel JF et al (2021) Baseline characteristics and survival of an Australian interstitial pneumonia with autoimmune features cohort. Respiration 100:853\u2013864. https:\/\/doi.org\/10.1159\/000515396","journal-title":"Respiration"},{"key":"8360_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031444","volume":"9","author":"H Kamiya","year":"2019","unstructured":"Kamiya H, Panlaqui OM (2019) Systematic review and meta-analysis of the prognosis and prognostic factors of interstitial pneumonia with autoimmune features. BMJ Open 9:e031444. https:\/\/doi.org\/10.1136\/bmjopen-2019-031444","journal-title":"BMJ Open"},{"key":"8360_CR16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/resp.13254","volume":"23","author":"BT Kelly","year":"2018","unstructured":"Kelly BT, Moua T (2018) Overlap of interstitial pneumonia with autoimmune features with undifferentiated connective tissue disease and contribution of UIP to mortality. Respirology 23:600\u2013605. https:\/\/doi.org\/10.1111\/resp.13254","journal-title":"Respirology"},{"key":"8360_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/RTI.0b013e3182a21969","volume":"28","author":"BJ Bartholmai","year":"2013","unstructured":"Bartholmai BJ, Raghunath S, Karwoski RA et al (2013) Quantitative computed tomography imaging of interstitial lung diseases. J Thorac Imaging 28:298\u2013307. https:\/\/doi.org\/10.1097\/RTI.0b013e3182a21969","journal-title":"J Thorac Imaging"},{"key":"8360_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37720-5","volume":"14","author":"X Mei","year":"2023","unstructured":"Mei X, Liu Z, Singh A et al (2023) Interstitial lung disease diagnosis and prognosis using an AI system integrating longitudinal data. Nat Commun 14:2272. https:\/\/doi.org\/10.1038\/s41467-023-37720-5","journal-title":"Nat Commun"},{"key":"8360_CR19","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s10067-020-04938-3","volume":"39","author":"AM Ferrazza","year":"2020","unstructured":"Ferrazza AM, Gigante A, Gasperini ML et al (2020) Assessment of interstitial lung disease in systemic sclerosis using the quantitative CT algorithm CALIPER. Clin Rheumatol 39:1537\u20131542. https:\/\/doi.org\/10.1007\/s10067-020-04938-3","journal-title":"Clin Rheumatol"},{"key":"8360_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-025-03949-7","volume":"25","author":"J Guiot","year":"2025","unstructured":"Guiot J, Engelberts J, Henket M et al (2025) Fibrotic and vascular abnormalities quantified by an AI-based model are associated with outcomes in patients with idiopathic pulmonary fibrosis. BMC Pulm Med 25:488. https:\/\/doi.org\/10.1186\/s12890-025-03949-7","journal-title":"BMC Pulm Med"},{"key":"8360_CR21","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1007\/s00330-021-08482-9","volume":"32","author":"SA Si-Mohamed","year":"2022","unstructured":"Si-Mohamed SA, Nasser M, Colevray M et al (2022) Automatic quantitative computed tomography measurement of longitudinal lung volume loss in interstitial lung diseases. Eur Radiol 32:4292\u20134303. https:\/\/doi.org\/10.1007\/s00330-021-08482-9","journal-title":"Eur Radiol"},{"key":"8360_CR22","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0194-2024","volume":"34","author":"G Dixon","year":"2025","unstructured":"Dixon G, Thould H, Wells M et al (2025) A systematic review of the role of quantitative CT in the prognostication and disease monitoring of interstitial lung disease. Eur Respir Rev 34:240194. https:\/\/doi.org\/10.1183\/16000617.0194-2024","journal-title":"Eur Respir Rev"},{"key":"8360_CR23","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580\u20131588. https:\/\/doi.org\/10.1136\/ard.2010.138461","journal-title":"Ann Rheum Dis"},{"key":"8360_CR24","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 72:1747\u20131755. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"key":"8360_CR25","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D et al (2019) 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 71:1400\u20131412. https:\/\/doi.org\/10.1002\/art.40930","journal-title":"Arthritis Rheumatol"},{"key":"8360_CR26","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M et al (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76:1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"key":"8360_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R et al (2017) 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 69:35\u201345. https:\/\/doi.org\/10.1002\/art.39859","journal-title":"Arthritis Rheumatol"},{"key":"8360_CR28","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.41773","volume":"73","author":"SA Chung","year":"2021","unstructured":"Chung SA, Langford CA, Maz M et al (2021) 2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol 73:1366\u20131383. https:\/\/doi.org\/10.1002\/art.41773","journal-title":"Arthritis Rheumatol"},{"key":"8360_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/14397595.2019.1709944","volume":"31","author":"Y Tanaka","year":"2021","unstructured":"Tanaka Y, Kuwana M, Fujii T et al (2021) 2019 Diagnostic criteria for mixed connective tissue disease (MCTD): from the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases. Mod Rheumatol 31:29\u201333. https:\/\/doi.org\/10.1080\/14397595.2019.1709944","journal-title":"Mod Rheumatol"},{"key":"8360_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM et al (2013) An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733\u2013748. https:\/\/doi.org\/10.1164\/rccm.201308-1483ST","journal-title":"Am J Respir Crit Care Med"},{"key":"8360_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/406927","volume":"2013","author":"J Chen","year":"2013","unstructured":"Chen J, Shi Y, Wang X, Huang H, Ascherman D (2013) Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease. Clin Dev Immunol 2013:406927. https:\/\/doi.org\/10.1155\/2013\/406927","journal-title":"Clin Dev Immunol"},{"key":"8360_CR32","doi-asserted-by":"publisher","first-page":"210206","DOI":"10.1183\/16000617.0206-2021","volume":"31","author":"S Tomassetti","year":"2022","unstructured":"Tomassetti S, Poletti V, Ravaglia C et al (2022) Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives. Eur Respir Rev 31:210206. https:\/\/doi.org\/10.1183\/16000617.0206-2021","journal-title":"Eur Respir Rev"},{"key":"8360_CR33","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1056\/NEJMoa055120","volume":"354","author":"DP Tashkin","year":"2006","unstructured":"Tashkin DP, Elashoff R, Clements PJ et al (2006) Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354:2655\u20132666. https:\/\/doi.org\/10.1056\/NEJMoa055120","journal-title":"N Engl J Med"},{"key":"8360_CR34","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1007\/s10067-021-05794-5","volume":"40","author":"X Ma","year":"2021","unstructured":"Ma X, Tang R, Luo M et al (2021) Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis. Clin Rheumatol 40:3185\u20133193. https:\/\/doi.org\/10.1007\/s10067-021-05794-5","journal-title":"Clin Rheumatol"},{"key":"8360_CR35","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","volume":"4","author":"DP Tashkin","year":"2016","unstructured":"Tashkin DP, Roth MD, Clements PJ et al (2016) Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med 4:708\u2013719. https:\/\/doi.org\/10.1016\/S2213-2600(16)30152-7","journal-title":"Lancet Respir Med"},{"key":"8360_CR36","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/acr.25348","volume":"76","author":"SR Johnson","year":"2024","unstructured":"Johnson SR, Bernstein EJ, Bolster MB et al (2024) 2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases. Arthritis Care Res (Hoboken) 76:1051\u20131069. https:\/\/doi.org\/10.1002\/acr.25348","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"8360_CR37","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s11926-012-0246-6","volume":"14","author":"T Mimori","year":"2012","unstructured":"Mimori T, Nakashima R, Hosono Y (2012) Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment. Curr Rheumatol Rep 14:264\u2013274. https:\/\/doi.org\/10.1007\/s11926-012-0246-6","journal-title":"Curr Rheumatol Rep"},{"key":"8360_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.autrev.2018.07.013","volume":"18","author":"T Barba","year":"2019","unstructured":"Barba T, Fort R, Cottin V et al (2019) Treatment of idiopathic inflammatory myositis associated interstitial lung disease: a systematic review and meta-analysis. Autoimmun Rev 18:113\u2013122. https:\/\/doi.org\/10.1016\/j.autrev.2018.07.013","journal-title":"Autoimmun Rev"},{"key":"8360_CR39","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0140-6736(23)01736-1","volume":"403","author":"A Kronbichler","year":"2024","unstructured":"Kronbichler A, Bajema IM, Bruchfeld A, Mastroianni Kirsztajn G, Stone JH (2024) Diagnosis and management of ANCA-associated vasculitis. Lancet 403:683\u2013698. https:\/\/doi.org\/10.1016\/S0140-6736(23)01736-1","journal-title":"Lancet"},{"key":"8360_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S2213-2600(21)00354-4","volume":"10","author":"JM Naccache","year":"2022","unstructured":"Naccache JM, Jouneau S, Didier M et al (2022) Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med 10:26\u201334. https:\/\/doi.org\/10.1016\/S2213-2600(21)00354-4","journal-title":"Lancet Respir Med"},{"key":"8360_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.55563\/clinexprheumatol\/tdueis","volume":"41","author":"JA Huapaya","year":"2023","unstructured":"Huapaya JA, Boulougoura A, Fried J et al (2023) Long-term evaluation of pulmonary function and survival of patients with interstitial pneumonia with autoimmune features. Clin Exp Rheumatol 41:15\u201323. https:\/\/doi.org\/10.55563\/clinexprheumatol\/tdueis","journal-title":"Clin Exp Rheumatol"},{"key":"8360_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02317-5","volume":"24","author":"MA Nieto","year":"2023","unstructured":"Nieto MA, Sanchez-Pernaute O, Vadillo C et al (2023) Functional respiratory impairment and related factors in patients with interstitial pneumonia with autoimmune features (IPAF): multicenter study from NEREA registry. Respir Res 24:19. https:\/\/doi.org\/10.1186\/s12931-023-02317-5","journal-title":"Respir Res"},{"key":"8360_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2024.107577","volume":"224","author":"N Enomoto","year":"2024","unstructured":"Enomoto N, Yazawa S, Mochizuka Y et al (2024) Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: a prospective, multicentre cohort study. Respir Med 224:107577. https:\/\/doi.org\/10.1016\/j.rmed.2024.107577","journal-title":"Respir Med"},{"key":"8360_CR44","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1183\/09031936.02.00182002","volume":"19","author":"KR Flaherty","year":"2002","unstructured":"Flaherty KR, Toews GB, Travis WD et al (2002) Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 19:275\u2013283. https:\/\/doi.org\/10.1183\/09031936.02.00182002","journal-title":"Eur Respir J"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08360-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08360-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08360-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:04:21Z","timestamp":1789545861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08360-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["8360"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08360-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"9 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This single-center retrospective cohort study was approved by the Ethics Committee of Tomakomai City Hospital (IRB protocol #2022\u201330, approved December 22, 2022) and was conducted according to the tenets of the Declaration of Helsinki. The need for informed consent was waived owing to the retrospective nature of the study. Patients were provided the opportunity to opt out of participation.","order":1,"name":"Ethics","label":"Ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}